What Is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell of your body. It drives mitochondrial energy production, supports DNA repair, and activates sirtuins, a family of enzymes that regulate inflammation, stress responses, and aging .

NAD+ levels decline with age, and this decline has been associated with many degenerative processes, including those that affect joint tissue . Understanding how NAD+ influences joint health requires looking at the biology of cartilage, synovial tissue, and the inflammatory pathways that drive joint pain.

How NAD+ Relates to Joint Health

Cartilage Metabolism and NAD+

Cartilage is the smooth, protective tissue that cushions the ends of bones within joints. Unlike most tissues, cartilage has limited blood supply and regenerative capacity, making it vulnerable to cumulative damage over time.

Chondrocytes, the cells responsible for maintaining cartilage, depend on NAD+ for their metabolic function. Research has shown that NAD+ depletion in chondrocytes leads to mitochondrial dysfunction, reduced matrix production, and increased susceptibility to cell death .

In animal models of osteoarthritis (OA), the most common form of joint disease, NAD+ levels in cartilage tissue were found to be significantly lower than in healthy controls . This finding suggests that NAD+ depletion may be both a consequence and a contributing factor in cartilage degeneration.

Sirtuin Activation and Joint Protection

Sirtuins, particularly SIRT1 and SIRT6, have emerged as important players in joint health. These NAD+-dependent enzymes regulate inflammatory signaling, oxidative stress, and the expression of cartilage-protective genes .

SIRT1 has been shown to suppress the activity of matrix metalloproteinases (MMPs), enzymes that break down cartilage matrix. In OA, MMP overactivity is a major driver of cartilage destruction . By supplying the NAD+ needed to fuel sirtuin activity, NAD+ therapy may help maintain the balance between cartilage breakdown and repair.

SIRT6 also plays a role in controlling inflammatory cytokines such as IL-1beta and TNF-alpha, both of which are elevated in painful, degenerating joints .

Inflammation and Pain Signaling

Joint pain is driven largely by inflammation. Inflammatory cytokines irritate nerve endings in joint tissue, cause swelling, and accelerate tissue damage. NAD+ influences inflammatory pathways at multiple levels.

Through sirtuin activation, NAD+ helps suppress NF-kB, a master regulator of inflammatory gene expression . In animal models of arthritis, NAD+ precursor supplementation reduced joint inflammation and decreased pain-related behaviors .

Additionally, PARP enzymes, which consume NAD+ during DNA repair, become overactivated in chronically inflamed tissues. This creates a problematic cycle: inflammation drives DNA damage, PARP activation consumes NAD+, NAD+ depletion worsens inflammation. Breaking this cycle by restoring NAD+ levels is a key rationale for therapy.

Mitochondrial Function in Joint Tissue

Chondrocytes rely on mitochondria for energy and metabolic regulation. Mitochondrial dysfunction in joint tissue has been identified as a contributing factor in OA progression .

NAD+ is essential for mitochondrial electron transport and ATP production. Restoring NAD+ in chondrocytes has been shown to improve mitochondrial function and reduce oxidative stress in preclinical studies . This may help slow the degenerative processes that lead to joint pain.

Senescence and Joint Aging

Cellular senescence, the accumulation of dysfunctional cells that resist normal clearance, is increasingly recognized as a driver of joint degeneration. Senescent cells in joint tissue secrete inflammatory molecules collectively known as the senescence-associated secretory phenotype (SASP), which damages surrounding healthy tissue .

NAD+ and sirtuins help regulate cellular senescence pathways. In animal models, boosting NAD+ levels reduced the accumulation of senescent cells in joint tissue and decreased SASP-related inflammation .

What the Research Shows

The connection between NAD+ and joint health is supported by several lines of evidence, though important limitations remain:

• Consistent preclinical findings: Multiple animal studies demonstrate that NAD+ depletion worsens joint degeneration and that restoring NAD+ levels reduces inflammation, protects cartilage, and improves pain outcomes.
• Mechanistic clarity: The roles of NAD+-dependent sirtuins and PARPs in cartilage biology are well characterized at the molecular level.
• Limited human joint data: Clinical trials specifically measuring joint pain or osteoarthritis outcomes with NAD+ therapy have not yet been published. Human evidence is limited to trials measuring general health and metabolic endpoints.
• Not a replacement for standard care: NAD+ therapy is not a substitute for physical therapy, weight management, or medical treatments for joint conditions.

NAD+ Compared to Other Approaches for Joint Pain

NAD+ therapy is not the only peptide or supplement studied for joint health. Understanding how it compares to other options can help you and your physician make informed decisions:

• BPC-157: A peptide with strong preclinical data for tendon and ligament healing. It works through different mechanisms (angiogenesis, growth factor modulation) and may complement NAD+'s cellular energy and anti-inflammatory effects.
• TB-500: Another peptide studied for tissue repair and inflammation. It promotes cell migration and tissue remodeling.
• Glucosamine and chondroitin: Well-known supplements with mixed clinical results. They provide structural building blocks for cartilage but do not address the underlying cellular energy and inflammation issues that NAD+ targets.

Some physicians may recommend combining NAD+ with other therapies as part of a comprehensive approach to joint health. Discuss your options with your provider.

Safety and Side Effects

NAD+ therapy has a favorable safety profile in available clinical data. Side effects are generally mild and include flushing, nausea, chest tightness (with IV infusion), and injection site discomfort .

There are no known joint-specific side effects of NAD+ therapy. For a complete safety overview, see our NAD+ side effects guide. For dosing information, visit our NAD+ dosage guide.

How Form Blends Can Help

At Form Blends, we understand that joint pain affects quality of life in profound ways. Our licensed physicians can evaluate whether NAD+ therapy may support your joint health goals as part of a broader treatment strategy.

When you work with us, you receive:

• A personalized consultation with a licensed physician
• Pharmaceutical-grade NAD+ from licensed compounding pharmacies
• A protocol tailored to your specific joint health concerns
• Ongoing medical supervision and support

We take a comprehensive approach that considers all aspects of your joint health, not just one molecule. Our physicians can help you explore whether NAD+ therapy makes sense alongside your current care plan.

Frequently Asked Questions

Can NAD+ help with arthritis?

Preclinical research suggests that NAD+ restoration may reduce joint inflammation, protect cartilage, and slow degenerative processes associated with osteoarthritis. However, human clinical trials specific to arthritis outcomes have not been published. NAD+ is not an approved treatment for arthritis.

How long does it take for NAD+ to help with joint pain?

Individual responses vary. Because cartilage turnover is slow compared to other tissues, improvements in joint comfort may take several weeks to months of consistent therapy. Some individuals report reduced inflammation and discomfort sooner, particularly if systemic inflammation is a significant contributor to their pain.

Should I stop my other joint treatments if I start NAD+?

No. NAD+ therapy should complement, not replace, your existing joint care plan. Continue physical therapy, prescribed medications, and other treatments unless your physician advises otherwise.

Is NAD+ better than BPC-157 for joint pain?

They work through different mechanisms. BPC-157 focuses on tissue repair and angiogenesis, while NAD+ addresses cellular energy, inflammation, and sirtuin-mediated protection. Some clinicians recommend combining both as part of a comprehensive approach. Discuss your options with your physician.

Can NAD+ prevent joint problems?

There is no clinical evidence that NAD+ prevents joint disease in humans. However, the preclinical data on NAD+ and cartilage protection, combined with its role in reducing age-related inflammation, suggests a potential preventive rationale that warrants further research.